• search
For Quick Alerts
ALLOW NOTIFICATIONS  
For Daily Alerts

Ivermectin drug: Regular use of oral anti-parasitic drug may cut risk of contracting Covid-19, says Study

|
Google Oneindia News

New Delhi, May 11: Regular use of the oral antiparasitic drug ivermectin may significantly reduce the risk of contracting Covid-19, according to a review of available data by researchers who claim the medicine can help end the pandemic.

    Ivermectin divides experts | Goa approves drug for all | Explained | Oneindia News

    Ivermectin drug: Study says regular use of oral anti-parasitic drug may cut risk of contracting Covid-19

    The research, published in the May-June issue of the American Journal of Therapeutics, is the most comprehensive review of the available data on ivermectin taken from clinical, in vitro, animal, and real-world studies, its authors said.

    "We conducted the most comprehensive review of the available data on ivermectin," said Pierre Kory, president and chief medical officer of the Front Line Covid-19 Critical Care Alliance (FLCCC), a group of medical and scientific experts, which led the study.

    What is ivermectin drug? All you need to know about this cheap antiparasitic 'wonder drug'What is ivermectin drug? All you need to know about this cheap antiparasitic 'wonder drug'

    "We applied the gold standard to qualify the data reviewed before concluding that ivermectin can end this pandemic," Kory said in a statement.

    Ivermectin is an oral drug is used as a prescription medication to treat parasitic infections.

    A focus of the study was on the 27 controlled trials available in January 2021, 15 of which were randomised controlled trials (RCT's).

    For Daily Alerts
    Get Instant News Updates
    Enable
    x
    Notification Settings X
    Time Settings
    Done
    Clear Notification X
    Do you want to clear all the notifications from your inbox?
    Settings X
    X